Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cricut (CRCT) Cash & Equivalents (2020 - 2025)

Cricut's Cash & Equivalents history spans 6 years, with the latest figure at $256.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 10.37% year-over-year to $256.2 million; the TTM value through Dec 2025 reached $256.2 million, up 10.37%, while the annual FY2025 figure was $256.2 million, 10.37% up from the prior year.
  • Cash & Equivalents reached $256.2 million in Q4 2025 per CRCT's latest filing, up from $187.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $337.5 million in Q1 2021 to a low of $72.6 million in Q3 2023.
  • Average Cash & Equivalents over 5 years is $216.8 million, with a median of $228.5 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: soared 701.03% in 2021, then crashed 52.95% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $241.6 million in 2021, then decreased by 6.89% to $224.9 million in 2022, then plummeted by 36.79% to $142.2 million in 2023, then skyrocketed by 63.26% to $232.1 million in 2024, then rose by 10.37% to $256.2 million in 2025.
  • Per Business Quant, the three most recent readings for CRCT's Cash & Equivalents are $256.2 million (Q4 2025), $187.9 million (Q3 2025), and $298.1 million (Q2 2025).